首页> 外文期刊>American Journal of Clinical Oncology: Cancer Clinical Trials >ACR–ASTRO Practice Parameter for the Performance of Proton Beam Radiation Therapy
【24h】

ACR–ASTRO Practice Parameter for the Performance of Proton Beam Radiation Therapy

机译:用于质子束放射疗法性能的ACR-Astro实践参数

获取原文
获取原文并翻译 | 示例
       

摘要

Aim/Objectives/Background: The American College of Radiology (ACR) and the American Society for Radiation Oncology (ASTRO) have jointly developed the following practice parameter for proton beam radiation therapy. Proton radiotherapy is the application of a high-energy proton beam to a patient in a clinical setting with therapeutic intent. Proton radiotherapy may permit improved therapeutic ratios with lower doses to sensitive normal structures and greater dose to target tumor tissues. Methods: A literature search was performed to identify published articles regarding clinical outcomes, reviews, quality assurance methodologies, and guidelines and standards for proton radiation therapy. Selected articles are referenced in the text. The following recommendations are based on firsthand experiences of multiple clinical authorities who employ proton therapy and have been peer reviewed by experts at different practicing institutions. Results: This practice parameter is developed to serve as a tool in the appropriate application of this evolving technology in the care of cancer patients or other patients with conditions where radiation therapy is indicated. It addresses clinical implementation of proton radiation therapy, including personnel qualifications, quality assurance standards, indications, and suggested documentation. Conclusions: This practice parameter is a tool to guide technical use of proton therapy and does not assess the relative clinical indication of proton radiotherapy when compared with other forms of radiotherapy, but to focus on the best practices required to deliver proton therapy safely and effectively, when clinically indicated. Costs of proton treatments are high, and the economic costs of proton radiotherapy may also need to be considered.
机译:目标/目标/背景:美国放射学院(ACR)和美国放射肿瘤学会(Astro)共同开发了用于质子束放射治疗的以下实践参数。质子放射疗法是用治疗意图施加高能质子束在临床环境中的患者施用。质子放射疗法可以允许改善的治疗比,较低剂量敏感正常结构和更大的剂量以靶向肿瘤组织。方法:进行文献搜索,以识别关于质子放射治疗的临床结果,评论,质量保证方法以及指南和标准的发布文章。在文本中引用了所选文章。以下建议基于雇用质子疗法的多个临床当局的第一手经历,并通过不同练习机构的专家对同行进行审查。结果:这种做法参数是开发的,作为适当应用这种不断发展的技术的工具,在癌症患者或其他患者中表明了放射治疗的条件。它涉及质子放射治疗的临床实施,包括人员资格,质量保证标准,迹象和建议的文件。结论:这种做法参数是一种用于指导质子疗法的技术使用的工具,与其他形式的放射疗法相比,不评估质子放疗的相对临床指示,但要关注安全有效地提供质子疗法所需的最佳实践,临床上指出。质子处理的成本很高,也可能考虑质子放疗的经济成本。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号